Clinical Trials Logo

Filter by:
NCT ID: NCT04592887 Completed - Bone Metastasis Clinical Trials

Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

FAST-01
Start date: November 3, 2020
Phase: N/A
Study type: Interventional

This purpose of this study is to assess the feasibility of FLASH radiotherapy for the palliative treatment of painful bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.

NCT ID: NCT04592783 Completed - Clinical trials for Hypertension in the Obstetric Context

Postpartum Hypertension, Tight vs Liberal Control Trial

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

To determine if treatment of less severe hypertension in the postpartum period results in a lower frequency of maternal morbidity.

NCT ID: NCT04592718 Completed - Anxiety Clinical Trials

Four-week Breathing Interventions on Gut Symptoms, Heart Rate Variability, and Psychological Measures in Runners

Start date: October 20, 2020
Phase: N/A
Study type: Interventional

Recent research has suggested that stress and anxiety levels are associated with gastrointestinal (GI) symptoms in endurance athletes (runners, cyclists, triathletes). Yet, there has been limited attempt to evaluate whether GI symptoms during running can be mitigated by interventions designed to reduce stress and anxiety. Thus, this study will evaluate the effects of four-week slow deep breathing and mindful breath counting interventions on subjective and objective measures of stress/anxiety and GI symptoms in runners with mild-to-high anxiety and that are prone to GI symptoms during runs.

NCT ID: NCT04592627 Completed - Stroke Clinical Trials

Facial and Body Motion Technology and Stroke

Start date: October 14, 2020
Phase:
Study type: Observational

The purpose of this study is to customize privacy protected facial expression and body motion tracking for use in the home environment by stroke survivor-informal caregiver dyads by investigating within a simulated home environment, background variability,possible occlusions, privacy considerations, and the motor weaknesses, gait impairments, and facial expressions of stroke survivors and to determine the acceptability of the customized facial expression and body motion technology in stroke survivors and their informal caregivers.

NCT ID: NCT04592575 Completed - Clinical trials for Brain Injuries, Traumatic

Determining the Incidence of Vestibular Dysfunction in Traumatic Brain Injury Patients

Start date: December 15, 2020
Phase:
Study type: Observational

The purpose of this study is to determine the incidence of vestibular dysfunction in traumatic brain injury patients admitted to acute inpatient rehabilitation. This study also seeks to validate the AbilityLab Vestibular Screening Tool (AVeST) and the AVeST+, tools designed to quickly screen individuals for vestibular dysfunction following traumatic brain injury.

NCT ID: NCT04592549 Completed - SARS-CoV-2 Clinical Trials

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

Start date: December 4, 2020
Phase: Phase 1
Study type: Interventional

This is a phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of ADM03820 administered as IM injections in healthy adults for the prevention of COVID-19.

NCT ID: NCT04592484 Completed - Clinical trials for Advanced Solid Tumor

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Start date: September 15, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a first-in-human, Phase 1/2 open-label, multicenter, dose escalation, safety, pharmacodynamic, and PK study of CDK-002 in subjects with advanced/metastatic, recurrent, injectable solid tumors, whose disease has progressed despite receiving standard of care treatment. CDK 002 will be administered intratumorally (IT). Part A will enroll subjects with advanced/metastatic, recurrent, injectable solid tumors with emphasis on head and neck squamous cell cancer (HNSCC), triple negative breast cancer (TNBC), anaplastic thyroid carcinoma (ATC) and cutaneous squamous cell carcinoma (cSCC).

NCT ID: NCT04592419 Completed - Macular Edema Clinical Trials

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

BEACON
Start date: September 25, 2020
Phase: Phase 3
Study type: Interventional

This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept, in participants with macular edema due to treatment-naïve branch (BRVO) or central retinal vein occlusion (CRVO).

NCT ID: NCT04592198 Completed - Clinical trials for Nausea With Vomiting Chemotherapy-Induced

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

Phase 2 study to compare efficacy, safety and PK of palonosetron, a long acting 5-HT3 receptor antagonist, by buccal film delivery compared to iv injection for chemotherapy induced nausea or vomiting (CINV). Subjects receive a single dose of palonosetron prior to moderately emetogenic chemotherapy.

NCT ID: NCT04592172 Completed - Sleep Clinical Trials

Impact of Bedtime Routines on Sleep and Development in Toddlers

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

Investigators will recruit up to 100 families (children aged 12.0 to 14.9 months and their primary caregivers) at their scheduled 12-month well child care infant visit at Temple Pediatric Care. The purpose of this randomized controlled trial is to examine the impact of implementation of a bedtime routine program, Connect, Calm, & Comfort: 3 Cs for Bedtime ZZZs, to promote better sleep and improve developmental outcomes in toddlers from primarily low-income families.